{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Skin+Disorder&page=27", "query": { "condition": "Skin Disorder", "page": 27 }, "page_size": 10 }, "pagination": { "page": 27, "page_size": 10, "total_count": 16119, "total_pages": 1612, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Skin+Disorder&page=28&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Skin+Disorder&page=26&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-29T03:07:28.091Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04150042", "title": "SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pancreatic Adenocarcinoma Metastatic", "BRCA1 Mutation", "BRCA2 Mutation", "Pancreatic Acinar Cell Carcinoma", "Pancreatic Ductal Adenocarcinoma", "Pancreatic Cancer", "Metastatic Pancreatic Cancer", "Metastatic Pancreatic Ductal Adenocarcinoma", "Breast Cancer Metastatic", "Breast Cancer Stage IV", "Pancreatic Cancer Stage IV", "HER2-negative Breast Cancer", "HER2 Negative Breast Carcinoma", "Adenocarcinoma of the Breast", "PALB2 Gene Mutation", "Pancreas Cancer, Metastatic", "Pancreas Cancer, Recurrent", "Pancreas Cancer", "Stage IV Pancreatic Cancer", "Stage 4 Pancreatic Cancer" ], "interventions": [ { "name": "Melphalan", "type": "DRUG" }, { "name": "BCNU", "type": "DRUG" }, { "name": "Vitamin B12B", "type": "DRUG" }, { "name": "Vitamin C", "type": "DRUG" }, { "name": "Autologous Hematopoietic Stem Cells", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "General Oncology, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2021-01-13", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-01-29", "last_synced_at": "2026-10-29T03:07:28.091Z", "location_count": 2, "location_summary": "Boston, Massachusetts • New York, New York", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04150042" }, { "nct_id": "NCT06940869", "title": "Network to Understand Reproductive Rheumatology Registry", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatic Diseases", "Pregnancy Related", "Pregnancy Interest", "Reproductive Health", "Autoimmune Diseases" ], "interventions": [ { "name": "NURTURE Registry", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "12 Years to 55 Years · Female only" }, "enrollment_count": 1000, "start_date": "2025-05-19", "completion_date": "2035-01-01", "has_results": false, "last_update_posted_date": "2026-05-07", "last_synced_at": "2026-10-29T03:07:28.091Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06940869" }, { "nct_id": "NCT02127970", "title": "Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Abscess", "Wound Infection", "Surgical Site Infection", "Cellulitis" ], "interventions": [ { "name": "Dalbavancin", "type": "DRUG" }, { "name": "Dalbavancin-matching Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Durata Therapeutics Inc., an affiliate of Allergan plc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 698, "start_date": "2014-04-18", "completion_date": "2015-03-11", "has_results": true, "last_update_posted_date": "2018-09-28", "last_synced_at": "2026-10-29T03:07:28.091Z", "location_count": 25, "location_summary": "Montgomery, Alabama • Anaheim, California • Long Beach, California + 18 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Modesto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02127970" }, { "nct_id": "NCT07213973", "title": "Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hidradenitis Suppurativa (HS)" ], "interventions": [ { "name": "Povorcitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 40, "start_date": "2026-02-02", "completion_date": "2028-03-25", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-29T03:07:28.091Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Farmington, Connecticut + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07213973" }, { "nct_id": "NCT00436605", "title": "Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Melanoma", "Stage IIIA Melanoma", "Stage IIIB Melanoma", "Stage IIIC Melanoma", "Stage IV Melanoma" ], "interventions": [ { "name": "dasatinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2006-12", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2014-05-15", "last_synced_at": "2026-10-29T03:07:28.091Z", "location_count": 2, "location_summary": "New Haven, Connecticut • Minneapolis, Minnesota", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00436605" }, { "nct_id": "NCT03568656", "title": "Study to Evaluate CCS1477 in Advanced Tumours", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Metastatic Castration-Resistant Prostate Cancer", "Metastatic Breast Cancer", "Non-small Cell Lung Cancer", "Advanced Solid Tumors" ], "interventions": [ { "name": "CCS1477", "type": "DRUG" }, { "name": "Abiraterone acetate", "type": "DRUG" }, { "name": "Enzalutamide", "type": "DRUG" }, { "name": "Darolutamide", "type": "DRUG" }, { "name": "Olaparib", "type": "DRUG" }, { "name": "Atezolizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CellCentric Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 219, "start_date": "2018-07-23", "completion_date": "2025-07-06", "has_results": true, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-29T03:07:28.091Z", "location_count": 2, "location_summary": "Boston, Massachusetts • Philadelphia, Pennsylvania", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03568656" }, { "nct_id": "NCT02095756", "title": "Combination Alexandrite Laser and Topical Therapy vs Topical Therapy Alone for Treatment of Melasma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Melasma" ], "interventions": [ { "name": "755nm Alexandrite Laser and Lytera Skin Brightening System (Non-Hydroquinone Topical Therapy)", "type": "OTHER" }, { "name": "Lytera Skin Brightening System (Non-hydroquinone topical therapy)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Cynosure, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 20, "start_date": "2013-06", "completion_date": "2014-06", "has_results": false, "last_update_posted_date": "2015-07-31", "last_synced_at": "2026-10-29T03:07:28.091Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02095756" }, { "nct_id": "NCT01421966", "title": "Evaluation of CureXcell® in Treating Lower Extremity Chronic Ulcers in Adults With Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lower Extremity Chronic Ulcers in Diabetics" ], "interventions": [ { "name": "CureXcell®", "type": "BIOLOGICAL" }, { "name": "Sham injection", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Macrocure Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 285, "start_date": "2011-08", "completion_date": "2015-10", "has_results": false, "last_update_posted_date": "2015-12-07", "last_synced_at": "2026-10-29T03:07:28.091Z", "location_count": 31, "location_summary": "Glendale, Arizona • Mesa, Arizona • Phoenix, Arizona + 28 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01421966" }, { "nct_id": "NCT01708551", "title": "Histological Analysis Following Ulthera System Treatment for Hyperhidrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hyperhidrosis" ], "interventions": [ { "name": "Ulthera System Treatment", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Ulthera, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 59, "start_date": "2012-08", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2017-12-14", "last_synced_at": "2026-10-29T03:07:28.091Z", "location_count": 1, "location_summary": "Aventura, Florida", "locations": [ { "city": "Aventura", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01708551" }, { "nct_id": "NCT02503137", "title": "A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Androgenetic Alopecia" ], "interventions": [ { "name": "Topical SM04554 solution", "type": "DRUG" }, { "name": "Topical vehicle solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biosplice Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "18 Years to 65 Years · Male only" }, "enrollment_count": 49, "start_date": "2015-08", "completion_date": "2016-04", "has_results": true, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-10-29T03:07:28.091Z", "location_count": 5, "location_summary": "Clinton Township, Michigan • Cleveland, Ohio • College Station, Texas + 2 more", "locations": [ { "city": "Clinton Township", "state": "Michigan" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "College Station", "state": "Texas" }, { "city": "Houston", "state": "Texas" }, { "city": "Lynchburg", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02503137" } ] }